ZYMUTEST HIA Mono strip IgGAM
In EU: This Product is CE Marked.
Research Use Only in Canada.
Enzyme immuno-assay designed for measuring globally all heparin-dependent antibodies, whether the isotype is: IgG, IgM and IgA, in human plasma or serum, or in any biological fluid where these antibodies must be measured. This assay is proposed as screening, as an early identification of heparin treated patients presenting a risk to develop HIT or HITT. This assay measures the whole of antibodies. It offers the highest sensitivity as all isotypes are detected. It is the preferred assay when an early detection of heparin dependent antibodies is required for assessing the development risk of HIT/HITT.
This kit allows individual testing as it offers a packaging for 4 individual 8 well strips along with controls.
|SKU ID#||Packaging||Website Links|
|ARK041D||Kit of 32 tests||www.hit-assay.com|
|Assay Characteristics||Kit Components||Applications|
|Micro ELISA Plate (4 strips of 8 wells) |
2x HIA Sample Diluent.
4x HIA IgGAM Positive Control.
4x Negative Control.
4x Platelet Lysate.
4x Anti-IgG (Fcγ)-IgM (µ)-IgA(α)-HRP IC
1x Conjugate Diluent.
4x Wash Solution.
|Individual test. |
Assessment of the risk to develop HIT/HITT, in patients treated with heparins (Unfractionated or LMWH): presence of antibodies is a risk indicator for development of HIT/HITT.
Clinical suspicion of HIT during heparin therapy.
Streamline Laboratory ProceduresReady-to-use reagents and buffers, from Medicago AB. Available in tablets and pouches.
|Package Inserts||MSDS||Tech Specs||Adaptations|
|ZYM. HIA IgGAM - CE
ZYM. HIA IgGAM - 501(k)
|ZYM. HIA IgGAM||N/A||N/A|